Phase I trial of SAR 279356 in volunteers.

Trial Profile

Phase I trial of SAR 279356 in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Feb 2012

At a glance

  • Drugs F-598 (Primary)
  • Indications Methicillin-resistant Staphylococcus aureus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Sep 2010 Status changed from planning to recruiting.
    • 22 Dec 2009 New trial record
    • 14 Dec 2009 This trial will be initiated in 2010 according to a sanofi-aventis and Alopexx Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top